Correction: Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine (PLoS ONE (2017) 12:4 (e0175369) DOI: 10.1371/journal.pone.0175369);Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer's disease: Alleviation by pantethine

PLoS ONE

Volumn 12, Issue 4, 2017, Pages

  Van Gijsel Bonnello, Manuel ^a   Baranger, Kévin ^a   Benech, Philippe ^a   Rivera, Santiago ^a   Khrestchatisky, Michel ^a   De Reggi, Max ^a   Gharib, Bouchra ^a  

^a Mediterranée University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; HEXOSE PHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; PANTETHINE; PRESENILIN 1; MESSENGER RNA; PANTETHEINE;

5XFAD MOUSE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTROCYTE CULTURE; CELL ACTIVATION; CITRIC ACID CYCLE; CONTROLLED STUDY; GENOTYPE; GLYCOLYSIS; METABOLISM PARAMETERS; METABOLOMICS; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; WILD TYPE; ANALOGS AND DERIVATIVES; ANIMAL; ASTROCYTE; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY; PENTOSE PHOSPHATE CYCLE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; CITRIC ACID CYCLE; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GLYCOLYSIS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; INTERLEUKIN-1BETA; METABOLOMICS; MICE; MICE, TRANSGENIC; PANTETHEINE; PENTOSE PHOSPHATE PATHWAY; PRESENILIN-1; RNA, MESSENGER;

EID: 85017419768     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0194586     Document Type: Erratum

References (68)

1. Kalman M (2004) Glia reaction and reactive glia. In: Hertz L, editor. Non neuronal cells of the nervous system: function and dysfunction. Amsterdam: Elsevier. pp. 787-835.
2. Zhao J, O'Connor T, Vassar R. The contribution of activated astrocytes to Abeta production: implications for Alzheimer's disease pathogenesis. J Neuroinflammation. 2011; 8:150. https://doi.org/10.1186/1742-2094-8-150 PMID: 22047170
3. Kraft AW, Hu X, Yoon H, Yan P, Xiao Q, Wang Y, et al. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J. 2013; 27:187-198. https://doi.org/10.1096/fj.12- 208660 PMID: 23038755
4. Hong HS, Hwang EM, Sim HJ, Cho HJ, Boo JH, Oh SS, et al. Interferon gamma stimulates beta-secretase expression and sAPPbeta production in astrocytes. Biochem Biophys Res Commun. 2003; 07:922-927. PMID: 12878199
5. Orre M, Kamphuis W, Osborn LM, Jansen AH, Kooijman L, Bossers K, et al. Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction. Neurobiol Aging. 2014; 35:2746-2760. https://doi.org/10.1016/j.neurobiolaging.2014.06.004 PMID: 25002035
6. Iram T, Trudler D, Kain D, Kanner S, Galron R, Vassar R, et al. Astrocytes from old Alzheimer's disease mice are impaired in Abeta uptake and in neuroprotection. Neurobiol Dis. 2016; 96:84-94. https://doi.org/10.1016/j.nbd.2016.08.001 PMID: 27544484
7. Wang G, Silva J, Dasgupta S, Bieberich E. Long-chain ceramide is elevated in presenilin 1 (PS1M146V) mouse brain and induces apoptosis in PS1 astrocytes. Glia. 2008; 56:449-456. https://doi.org/10.1002/glia.20626 PMID: 18205190
8. Nilsen LH, Witter MP, Sonnewald U. Neuronal and astrocytic metabolism in a transgenic rat model of Alzheimer's disease. J Cereb Blood Flow Metab. 2014; 34:906-914. https://doi.org/10.1038/jcbfm. 2014.37 PMID: 24594625
9. Xu J, Begley P, Church SJ, Patassini S, Hollywood KA, Jullig M, et al. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder. Biochim Biophys Acta. 2016; 1862:1084-1092. https://doi.org/10.1016/j.bbadis.2016.03.001 PMID: 26957286
10. Wilkins HM, Swerdlow RH. Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease. Curr Top Med Chem. 2016; 16:849-857. PMID: 26311426
11. Zhang W, Bai M, Xi Y, Hao J, Zhang Z, Su C, et al. Multiple inflammatory pathways are involved in the development and progression of cognitive deficits in APPswe/PS1dE9 mice. Neurobiol Aging. 2012; 33:2661-2677. https://doi.org/10.1016/j.neurobiolaging.2011.12.023 PMID: 22277264
12. Heneka MT, O'Banion MK, Terwel D, Kummer MP. Neuroinflammatory processes in Alzheimer's disease. J Neural Transm. 2010; 117:919-947. https://doi.org/10.1007/s00702-010-0438-z PMID: 20632195
13. Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin- 6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis Assoc Disord. 1998; 12:215-227. PMID: 9772027
14. Lynch MA. Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1 beta? Prog Neurobiol. 1998; 56:571-589. PMID: 9775404
15. Morimoto K, Horio J, Satoh H, Sue L, Beach T, Arita S, et al. Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology. J Alzheimers Dis. 2011; 25:59-76. https://doi.org/10.3233/JAD- 2011-101815 PMID: 21368376
16. Baranger K, Marchalant Y, Bonnet AE, Crouzin N, Carrete A, Paumier JM, et al. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease. Cell Mol Life Sci. 2016; 73:217-236. https://doi.org/10.1007/s00018-015-1992-1 PMID: 26202697
17. Py NA, Bonnet AE, Bernard A, Marchalant Y, Charrat E, Checler F, et al. Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP. Front Aging Neurosci. 2014; 6:247. https://doi.org/10.3389/fnagi. 014.00247 PMID: 25278878
18. Girard SD, Jacquet M, Baranger K, Migliorati M, Escoffier G, Bernard A, et al. Onset of hippocampusdependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease. Hippocampus. 2014; 24:762-772. https://doi.org/10.1002/hipo.22267 PMID: 24596271
19. Landel V, Baranger K, Virard I, Loriod B, Khrestchatisky M, Rivera S, et al. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease. Mol Neurodegener. 2014; 9:33. https://doi.org/10.1186/1750-1326-9-33 PMID: 25213090
20. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006; 26:10129-10140. https://doi.org/10.1523/JNEUROSCI.1202-06.2006 PMID: 17021169
21. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297:353-356. https://doi.org/10.1126/science.1072994 PMID: 12130773
22. Lauritzen I, Pardossi-Piquard R, Bourgeois A, Pagnotta S, Biferi MG, Barkats M, et al. Intraneuronal aggregation of the beta-CTF fragment of APP (C99) induces Abeta-independent lysosomal-autophagic pathology. Acta Neuropathol. 2016; 132:257-276. https://doi.org/10.1007/s00401-016-1577-6 PMID: 27138984
23. Garwood CJ, Pooler AM, Atherton J, Hanger DP, Noble W. Astrocytes are important mediators of Abeta-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2011; 2:e167. https://doi.org/10.1038/cddis.2011.50 PMID: 21633390
24. Tuppo EE, Arias HR. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol. 2005; 37:289-305. https://doi.org/10.1016/j.biocel.2004.07.009 PMID: 15474976
25. Shaftel SS, Griffin WS, O'Banion MK. The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation. 2008; 5:7. https://doi.org/10.1186/1742-2094-5-7 PMID: 18302763
26. Hou L, Liu Y, Wang X, Ma H, He J, Zhang Y, et al. The effects of amyloid-beta42 oligomer on the proliferation and activation of astrocytes in vitro. In Vitro Cell Dev Biol Anim. 2011; 47:573-580. https://doi.org/10.1007/s11626-011-9439-y PMID: 21858610
27. Narayan P, Holmstrom KM, Kim DH, Whitcomb DJ, Wilson MR, St George-Hyslop P, et al. Rare individual amyloid-beta oligomers act on astrocytes to initiate neuronal damage. Biochemistry. 2014; 53:2442-2453. https://doi.org/10.1021/bi401606f PMID: 24717093
28. Ashok BS, Ajith TA, Sivanesan S. Hypoxia-inducible factors as neuroprotective agent in Alzheimer's disease. Clin Exp Pharmacol Physiol. 2016.
29. Schubert D, Soucek T, Blouw B. The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide. Eur J Neurosci. 2009; 29:1323-1334. https://doi.org/10.1111/j.1460-9568.2009.06712.x PMID: 19519624
30. Soucek T, Cumming R, Dargusch R, Maher P, Schubert D. The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron. 2003; 39:43-56. PMID: 12848931
31. Brunetti D, Dusi S, Giordano C, Lamperti C, Morbin M, Fugnanesi V, et al. Pantethine treatment is effective in recovering the disease phenotype induced by ketogenic diet in a pantothenate kinase-associated neurodegeneration mouse model. Brain. 2013; 137:57-68. https://doi.org/10.1093/brain/awt325 PMID: 24316510
32. Cornille E, Abou-Hamdan M, Khrestchatisky M, Nieoullon A, de Reggi M, Gharib B. Enhancement of L- 3-hydroxybutyryl-CoA dehydrogenase activity and circulating ketone body levels by pantethine. Relevance to dopaminergic injury. BMC Neurosci. 2010; 11:51. https://doi.org/10.1186/1471-2202-11-51 PMID: 20416081
33. Rana A, Seinen E, Siudeja K, Muntendam R, Srinivasan B, van der Want JJ, et al. Pantethine rescues a Drosophila model for pantothenate kinase-associated neurodegeneration. Proc Natl Acad Sci U S A. 2010; 107:6988-6993. https://doi.org/10.1073/pnas.0912105107 PMID: 20351285
34. Rothmann M, Kang M, Villa R, Ntai I, La Clair JJ, Kelleher NL, et al. Metabolic perturbation of an essential pathway: evaluation of a glycine precursor of coenzyme A. J Am Chem Soc. 2013; 135:5962-5965. https://doi.org/10.1021/ja400795m PMID: 23550886
35. Kavian N, Marut W, Servettaz A, Nicco C, Chereau C, Lemarechal H, et al. Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding. Arthritis Rheumatol. 2015; 67:1881-1890. https://doi.org/10.1002/art.39121 PMID: 25776044
36. Penet MF, Abou-Hamdan M, Coltel N, Cornille E, Grau GE, de Reggi M, et al. Protection against cerebral malaria by the low-molecular-weight thiol pantethine. Proc Natl Acad Sci U S A. 2008; 105:1321-1326. https://doi.org/10.1073/pnas.0706867105 PMID: 18195363
37. Ogier C, Creidy R, Boucraut J, Soloway PD, Khrestchatisky M, Rivera S. Astrocyte reactivity to Fas activation is attenuated in TIMP-1 deficient mice, an in vitro study. BMC Neurosci. 2005; 6:68. https://doi.org/10.1186/1471-2202-6-68 PMID: 16316466
38. Sbai O, Ould-Yahoui A, Ferhat L, Gueye Y, Bernard A, Charrat E, et al. Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes. Glia. 2010; 58:344-366. https://doi.org/10.1002/glia.20927 PMID: 19780201
39. Stine WB Jr, Dahlgren KN, Krafft GA, LaDu MJ. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem. 2003; 278:11612-11622. https://doi.org/10.1074/jbc.M210207200 PMID: 12499373
40. Dahlgren KN, Manelli AM, Stine WB Jr, Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem. 2002; 277:32046-32053. https://doi.org/10.1074/jbc.M201750200 PMID: 12058030
41. van Gijsel-Bonnello M, Acar N, Molino Y, Bretillon L, Khrestchatisky M, de Reggi M, et al. Pantethine Alters Lipid Composition and Cholesterol Content of Membrane Rafts, With Down-Regulation of CXCL12-Induced T Cell Migration. J Cell Physiol. 2015.
42. Stanton RC, Seifter JL, Boxer DC, Zimmerman E, Cantley LC. Rapid release of bound glucose-6-phosphate dehydrogenase by growth factors. Correlation with increased enzymatic activity. J Biol Chem. 1991; 266:12442-12448. PMID: 2061319
43. Zhang Z, Yu J, Stanton RC. A method for determination of pyridine nucleotides using a single extract. Anal Biochem. 2000; 285:163-167. https://doi.org/10.1006/abio.2000.4701 PMID: 10998277
44. Bergmeyer HU (1963) Methods of enzymatic analysis: Verlag Chemie.
45. Almeida AS, Queiroga CS, Sousa MF, Alves PM, Vieira HL. Carbon monoxide modulates apoptosis by reinforcing oxidative metabolism in astrocytes: role of Bcl-2. J Biol Chem. 2012; 287:10761-10770. https://doi.org/10.1074/jbc.M111.306738 PMID: 22334654
46. Sauer SW, Okun JG, Schwab MA, Crnic LR, Hoffmann GF, Goodman SI, et al. Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A. J Biol Chem. 2005; 280:21830-21836. https://doi.org/10.1074/jbc.M502845200 PMID: 15840571
47. Birch-Machin MA, Turnbull DM. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol. 2001; 65:97-117. PMID: 11381612
48. Liu Y, Peterson DA, Kimura H, Schubert D. Mechanism of cellular 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem. 1997; 69:581-593. PMID: 9231715
49. Kisselev AF, Goldberg AL. Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Methods Enzymol. 2005; 398:364-378. https://doi.org/10.1016/S0076-6879(05) 98030-0 PMID: 16275343
50. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001; 292:468-472. https://doi.org/10.1126/science.1059796 PMID: 11292861
51. Gonzalez-Dominguez R, Garcia-Barrera T, Vitorica J, Gomez-Ariza JL. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease. Biochim Biophys Acta. 2014; 1842:2395-2402. https://doi.org/10.1016/j.bbadis.2014.09.014 PMID: 25281826
52. Pedros I, Petrov D, Allgaier M, Sureda F, Barroso E, Beas-Zarate C, et al. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease. Biochim Biophys Acta. 2014; 1842:1556-1566. https://doi.org/10.1016/j.bbadis.2014.05.025 PMID: 24887203
53. Bouzier-Sore AK, Bolanos JP. Uncertainties in pentose-phosphate pathway flux assessment underestimate its contribution to neuronal glucose consumption: relevance for neurodegeneration and aging. Front Aging Neurosci. 2015; 7:89. https://doi.org/10.3389/fnagi.2015.00089 PMID: 26042035
54. Gibson GE, Park LC, Sheu KF, Blass JP, Calingasan NY. The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem Int. 2000; 36:97-112. PMID: 10676873
55. Kaneko I, Yamada N, Sakuraba Y, Kamenosono M, Tutumi S. Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue. J Neurochem. 1995; 65:2585-2593. PMID: 7595555
56. Shi Q, Xu H, Yu H, Zhang N, Ye Y, Estevez AG, et al. Inactivation and reactivation of the mitochondrial alpha-ketoglutarate dehydrogenase complex. J Biol Chem. 2011; 286:17640-17648. https://doi.org/10.1074/jbc.M110.203018 PMID: 21454586
57. Allaman I, Gavillet M, Belanger M, Laroche T, Viertl D, Lashuel HA, et al. Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability. J Neurosci. 2010; 30:3326-3338. https://doi.org/10.1523/JNEUROSCI.5098-09.2010 PMID: 20203192
58. Fu W, Shi D, Westaway D, Jhamandas JH. Bioenergetic mechanisms in astrocytes may contribute to amyloid plaque deposition and toxicity. J Biol Chem. 2015; 290:12504-12513. https://doi.org/10.1074/jbc.M114.618157 PMID: 25814669
59. Bahety P, Tan YM, Hong Y, Zhang L, Chan EC, Ee PL. Metabotyping of docosahexaenoic acid-treated Alzheimer's disease cell model. PLoS One. 2014; 9:e90123. https://doi.org/10.1371/journal. pone.0090123 PMID: 24587236
60. Pruss RM. Thy-1 antigen on astrocytes in long-term cultures of rat central nervous system. Nature. 1979; 280:688-690. PMID: 471047
61. Lauritzen I, Pardossi-Piquard R, Bauer C, Brigham E, Abraham JD, Ranaldi S, et al. The beta-secretase-derived C-terminal fragment of betaAPP, C99, but not Abeta, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus. J Neurosci. 2012; 32:16243-16255a. https://doi.org/10.1523/JNEUROSCI.2775-12.2012 PMID: 23152608
62. Stenovec M, Trkov S, Lasic E, Terzieva S, Kreft M, Rodriguez Arellano JJ, et al. Expression of familial Alzheimer disease presenilin 1 gene attenuates vesicle traffic and reduces peptide secretion in cultured astrocytes devoid of pathologic tissue environment. Glia. 2016; 64:317-329. https://doi.org/10.1002/glia.22931 PMID: 26462451
63. Aguirre-Rueda D, Guerra-Ojeda S, Aldasoro M, Iradi A, Obrador E, Mauricio MD, et al. WIN 55, 212-2, agonist of cannabinoid receptors, prevents amyloid beta1-42 effects on astrocytes in primary culture. PLoS One. 2015; 10:e0122843. https://doi.org/10.1371/journal.pone.0122843 PMID: 25874692
64. Valles SL, Dolz-Gaiton P, Gambini J, Borras C, Lloret A, Pallardo FV, et al. Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPAR gamma expression in cultured astrocytes. Brain Res. 2010; 1312:138-144. https://doi.org/10.1016/j.brainres.2009.11. 044 PMID: 19948157
65. Mechlovich D, Amit T, Bar-Am O, Mandel S, Youdim MB, Weinreb O. The novel multi-target iron chelator, M30 modulates HIF-1alpha-related glycolytic genes and insulin signaling pathway in the frontal cortex of APP/PS1 Alzheimer's disease mice. Curr Alzheimer Res. 2014; 11:119-127. PMID: 24359498
66. Koivunen P, Hirsila M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem. 2007; 282:4524-4532. https://doi.org/10.1074/jbc.M610415200 PMID: 17182618
67. Serra-Perez A, Planas AM, Nunez-O'Mara A, Berra E, Garcia-Villoria J, Ribes A, et al. Extended ischemia prevents HIF1alpha degradation at reoxygenation by impairing prolyl-hydroxylation: role of Krebs cycle metabolites. J Biol Chem. 2010; 285:18217-18224. https://doi.org/10.1074/jbc.M110.101048 PMID: 20368331
68. Kallio PJ, Wilson WJ, O'Brien S, Makino Y, Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J Biol Chem. 1999; 274:6519-6525. PMID: 10037745